• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[如何启动、优化和停止药物治疗:在现实生活中的应用]

[How to initiate, optimise and stop pharmacological treatments: applications in real life].

作者信息

Scheen A J

出版信息

Rev Med Liege. 2015 Jan;70(1):49-53.

PMID:25902607
Abstract

Some patients are exposed to complex clinical situations, which impose a careful analysis of both the indications and contraindications of ongoing pharmacological treatments as well as of the dosing or drug adjustments to be proposed. This article illustrates some problems encountered when a new drug therapy is initiated, when medications with narrow therapeutic window should be supervised and when some drugs should be stopped mainly for safety reasons. The clinical case relates the story of a patient with type 2 diabetes, arterial hypertension and coronary heart disease, who presents a congestive heart failure associated with an episode of atrial fibrillation and a severe renal insufficiency.

摘要

一些患者面临复杂的临床情况,这需要对正在进行的药物治疗的适应证和禁忌证以及拟议的剂量或药物调整进行仔细分析。本文阐述了开始新的药物治疗、应监测治疗窗窄的药物以及主要出于安全原因应停用某些药物时所遇到的一些问题。该临床病例讲述了一名患有2型糖尿病、动脉高血压和冠心病的患者的故事,该患者出现了与房颤发作和严重肾功能不全相关的充血性心力衰竭。

相似文献

1
[How to initiate, optimise and stop pharmacological treatments: applications in real life].[如何启动、优化和停止药物治疗:在现实生活中的应用]
Rev Med Liege. 2015 Jan;70(1):49-53.
2
Drug dosing in elderly patients with chronic kidney disease.老年慢性肾脏病患者的药物剂量。
Clin Geriatr Med. 2013 Aug;29(3):657-705. doi: 10.1016/j.cger.2013.05.008.
3
Why maximum tolerated dose?为什么是最大耐受剂量?
Br J Clin Pharmacol. 2019 Oct;85(10):2213-2217. doi: 10.1111/bcp.14032. Epub 2019 Jul 22.
4
[How I treat...Recommendations for controlling and optimizing a pharmacological therapy].[我的治疗方法……控制和优化药物治疗的建议]
Rev Med Liege. 2014 Nov;69(11):581-5.
5
Drug dosing in patients with renal insufficiency in a hospital setting using electronic prescribing and automated reporting of estimated glomerular filtration rate.在医院环境中,利用电子处方和估算肾小球滤过率的自动报告对肾功能不全患者进行药物剂量调整。
Basic Clin Pharmacol Toxicol. 2014 May;114(5):407-13. doi: 10.1111/bcpt.12185. Epub 2014 Jan 25.
6
Dose adjustment guidelines for medications in patients with renal impairment: how consistent are drug information sources?肾功能损害患者药物剂量调整指南:药物信息来源的一致性如何?
Intern Med J. 2014 Jan;44(1):77-85. doi: 10.1111/imj.12291.
7
Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs.药物水平:常见药物的治疗性和中毒性血清/血浆浓度
J Clin Monit Comput. 1999 Dec;15(7-8):529-44. doi: 10.1023/a:1009935116877.
8
Obstetric therapeutics-how pharmacogenetics may inform drug therapy for pregnant women in the future.产科治疗学——药物遗传学如何为未来孕妇的药物治疗提供信息。
Obstet Gynecol Surv. 2013 Sep;68(9):650-4. doi: 10.1097/OGX.0b013e3182a66180.
9
[Role of Pharmacy in the Promotion of Drug Safety in Pharmacotherapy].[药学在药物治疗中促进用药安全的作用]
Yakugaku Zasshi. 2018;138(2):149-150. doi: 10.1248/yakushi.17-00174-F.
10
The majority of hospitalised patients have drug-related problems: results from a prospective study in general hospitals.大多数住院患者存在药物相关问题:综合医院前瞻性研究的结果
Eur J Clin Pharmacol. 2004 Nov;60(9):651-8. doi: 10.1007/s00228-004-0830-4. Epub 2004 Oct 2.